ZyVersa Therapeutics Inc (ZVSA)
1.08
-0.05
(-4.42%)
USD |
NASDAQ |
Nov 15, 16:00
1.06
-0.02
(-1.85%)
After-Hours: 20:00
ZyVersa Therapeutics Total Liabilities (Quarterly): 10.85M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 10.85M |
| March 31, 2024 | 10.43M |
| December 31, 2023 | 11.04M |
| September 30, 2023 | 13.15M |
| June 30, 2023 | 11.93M |
| Date | Value |
|---|---|
| March 31, 2023 | 17.86M |
| December 31, 2022 | 18.51M |
| September 30, 2022 | 14.15M |
| June 30, 2022 | 17.16M |
| December 31, 2021 | 13.63M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
10.43M
Minimum
Mar 2024
18.51M
Maximum
Dec 2022
13.87M
Average
13.39M
Median
Total Liabilities (Quarterly) Benchmarks
| NeuroBo Pharmaceuticals Inc | 9.193M |
| Dermata Therapeutics Inc | 1.918M |
| Cognition Therapeutics Inc | 11.36M |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 10.85M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 19.47M |
| Shareholders Equity (Quarterly) | 8.620M |